104 related articles for article (PubMed ID: 38778687)
1. [Safety of patients undergoing radical resection combined with paclitaxel-based hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer].
Mei JX; Zhao LY; Zhang WH; Liu K; Chen XL; Yang K; Hu JK
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):471-477. PubMed ID: 38778687
[No Abstract] [Full Text] [Related]
2. [Safety evaluation of hyperthermic intraperitoneal chemotherapy in patients with local advanced gastric cancer after radical resection for prevention of peritoneal metastasis].
Lin Y; Shen C; Guo XK; Li Y; Wang DD; Chen X; Wang Z; Wu K; Tao KX; Wu CQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jan; 25(1):48-55. PubMed ID: 35067034
[No Abstract] [Full Text] [Related]
3. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
4. Comparative Study of the Efficacy and Safety of Radical Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy in Locally Advanced Gastric Cancer: A Propensity Score-Matching Analysis.
Shen C; Lin Y; Guo X; Li Y; Wang D; Du Z; Hu P; Chen X; Zeng X; Lv J; Wu C; Tao K
Ann Surg Oncol; 2022 Dec; 29(13):8551-8563. PubMed ID: 35941344
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery.
Fan B; Bu Z; Zhang J; Zong X; Ji X; Fu T; Jia Z; Zhang Y; Wu X
BMC Cancer; 2021 Mar; 21(1):216. PubMed ID: 33653317
[TBL] [Abstract][Full Text] [Related]
6. Hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy versus systemic chemotherapy alone in locally advanced gastric cancer after D2 radical resection: a randomized-controlled study.
Yu P; Huang X; Huang L; Dai G; Xu Q; Fang J; Ye Z; Chai T; Du Y
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11491-11498. PubMed ID: 37392201
[TBL] [Abstract][Full Text] [Related]
7. [The safety and efficacy of prophylactic hyperthermic intraperitoneal chemotherapy for elderly patients with locally advanced gastric cancer: a propensity score matching analysis].
Yu T; Ma FH; An Q; Cao XL; Xiao G; Wu GJ
Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(36):2867-2873. PubMed ID: 37726993
[No Abstract] [Full Text] [Related]
8. Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer.
Graziosi L; Cantarella F; Mingrone E; Gunnellini M; Cavazzoni E; Liberati M; Donini A
Ann Ital Chir; 2013; 84(5):551-6. PubMed ID: 24140896
[TBL] [Abstract][Full Text] [Related]
9. Does hipec improve outcomes in gastric cancer patients treated with perioperative chemotherapy and radical surgery? A propensity-score matched analysis.
Diniz TP; da Costa WL; Fonseca de Jesus VH; Ribeiro HSC; Diniz AL; de Godoy AL; de Farias IC; Torres SM; Felismino TC; Coimbra FJF
J Surg Oncol; 2020 Apr; 121(5):823-832. PubMed ID: 31950511
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study.
Yu P; Ye Z; Dai G; Zhang Y; Huang L; Du Y; Cheng X
BMC Cancer; 2020 Nov; 20(1):1108. PubMed ID: 33198674
[TBL] [Abstract][Full Text] [Related]
11. [Effects of laparoscopic hyperthermic intraperitoneal perfusion chemotherapy combined with intraperitoneal and systemic chemotherapy treatment in patients with untreated gastric cancer with peritoneal metastasis].
Li S; Xue K; Dai HM; Wang YK; Shan F; Li ZY; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):442-447. PubMed ID: 37217352
[No Abstract] [Full Text] [Related]
12. Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer.
Morton M; Chambers LM; Costales AB; Chichura A; Gruner M; Horowitz MP; Rose PG; Yao M; Debernardo R; Michener C
Gynecol Oncol; 2021 Jan; 160(1):45-50. PubMed ID: 33067001
[TBL] [Abstract][Full Text] [Related]
13. Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients.
Costa WL; Coimbra FJ; Ribeiro HS; Diniz AL; de Godoy AL; Begnami M; Silva MJ; Fanelli MF; Mello CA
World J Surg Oncol; 2012 Sep; 10():195. PubMed ID: 22992263
[TBL] [Abstract][Full Text] [Related]
14. [Safety and efficacy of laparoscopic surgery in locally advanced gastric cancer patients with neoadjuvant chemotherapy combined with immunotherapy].
Lv JB; Yin YP; Zhang P; Cai M; Chen JH; Li W; Li G; Wang Z; Wang GB; Tao KX
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jan; 26(1):84-92. PubMed ID: 36650004
[No Abstract] [Full Text] [Related]
15. [Analysis of risk factors of pulmonary infection in patients over 60 years of age after radical resection for gastric cancer].
Yao Z; Yang H; Cui M; Xing J; Zhang C; Zhang N; Chen L; Liu M; Xu K; Tan F; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):164-171. PubMed ID: 30799539
[TBL] [Abstract][Full Text] [Related]
16. Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer.
Wu Z; Ma S; Jing S; Deng Q; Zheng Z; Wu K; Li J; Chen S; Tang R; Li X
Hepatogastroenterology; 2014 Jun; 61(132):972-7. PubMed ID: 26158151
[TBL] [Abstract][Full Text] [Related]
17. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
[TBL] [Abstract][Full Text] [Related]
18. Analysis of causes and prognostic impact of tube occlusion during hyperthermic intraperitoneal chemotherapy for appendiceal pseudomyxoma peritonei.
Liu Q; Jiao J; Li C; Chen Y; Wang B; Shi J; Yu G
World J Surg Oncol; 2024 May; 22(1):134. PubMed ID: 38769546
[TBL] [Abstract][Full Text] [Related]
19. Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma - the phase III "PREVENT"- (FLOT9) trial of the AIO /CAOGI /ACO.
Götze TO; Piso P; Lorenzen S; Bankstahl US; Pauligk C; Elshafei M; Amato G; Reim D; Bechstein WO; Königsrainer A; Mönig SP; Rau B; Schwarzbach M; Al-Batran SE
BMC Cancer; 2021 Oct; 21(1):1158. PubMed ID: 34715810
[TBL] [Abstract][Full Text] [Related]
20. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy vs. cytoreductive surgery alone for intrahepatic cholangiocarcinoma with peritoneal metastases: A retrospective cohort study.
Feng F; Gao Q; Wu Y; Liu C; Yu Y; Li B; Chu K; Yi B; Cheng Q; Jiang X
Eur J Surg Oncol; 2021 Sep; 47(9):2363-2368. PubMed ID: 34119376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]